From: Potential new therapeutic modality revealed through agent-based modeling of the neuromuscular junction and acetylcholinesterase inhibition
Inhibitor
k-inh (M-1 min-1)
k-age (h-1)
GA
7.4 * 10 6
0.036
GB
2.7* 10 7
0.228
GD
9.2* 10 7
6.6
GF
4.9* 10 8
0.099
VX
1.2* 10 8
0.019
VR
4.4* 10 8
0.005
Paraoxon
1.2* 10 6
0.186
DFP
1.3* 10 5
0.221